ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome

Clinical trial NCT05116761 · WITHDRAWN

Trial details

NCT number: NCT05116761
Sponsor: Direct Biologics, LLC
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Covid19 Postviral Syndrome Dyspnea

Start date: 2024-11-01
Primary completion: 2024-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.